ReviewClinical drug investigation2026

Clinical Trial Comparison of Dupilumab and Nemolizumab for Prurigo Nodularis FDA-Approved Biologic Therapy Selection in Prurigo Nodularis.

Anna Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.